Driehaus Capital Management’s Amgen AMGN Stock Holding History

Driehaus Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-879	Closed	-$253K	–	387
2023 Q4	$253K	Buy	+879	New	+$240K	﹤0.01%	363
2022 Q2	–	Sell	-137,830	Closed	-$33.3M	–	355
2022 Q1	$33.3M	Buy	+137,830	New	+$31.7M	0.41%	78
2019 Q1	–	Sell	-1,644	Closed	-$320K	–	397
2018 Q4	$320K	Sell	1,644 -20	-1%	-$3.9K	0.01%	357
2018 Q3	$345K	Buy	1,664 +576	+53%	+$114K	0.01%	421
2018 Q2	$201K	Sell	1,088 -311	-22%	-$55K	0.01%	453
2018 Q1	$239K	Sell	1,399 -281	-17%	-$51.6K	0.01%	459
2017 Q4	$292K	Hold	1,680	–	–	0.01%	468
2017 Q3	$313K	Sell	1,680 -1,177	-41%	-$209K	0.01%	437
2017 Q2	$492K	Sell	2,857 -65	-2%	-$10.6K	0.02%	411
2017 Q1	$479K	Sell	2,922 -3	-0.1%	-$498	0.02%	437
2016 Q4	$428K	Buy	+2,925	New	+$440K	0.02%	439

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Driehaus Capital Management's AMGN Position: Q1 2024 in Review

Driehaus Capital Management sold out of Amgen (AMGN) in Q1 2024, closing a stake of 879 shares — an estimated $253K sold.

Driehaus Capital Management first reported a position in AMGN in Q4 2016 and held it in 11 quarters. The position peaked at $33.3M in Q1 2022. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

Driehaus Capital Management reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
Driehaus Capital Management sold 879 Amgen shares in Q1 2024, an estimated $253K.
Driehaus Capital Management first reported a position in Amgen in Q4 2016 and held it in 11 quarters.
Driehaus Capital Management's Amgen position peaked at $33.3M in Q1 2022.
2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Driehaus Capital Management's 13F filing for Q1 2024, filed 15 May 2024.